Table 3. Therapeutic management over time.
1982–85
|
1986–89
|
1990–93
|
1994–97
|
||||||
---|---|---|---|---|---|---|---|---|---|
Period | No. | % | No. | % | No. | % | No. | % | P |
Resectable disease | |||||||||
Radiotherapya | 44 | 24.4 | 35 | 17.9 | 26 | 12.7 | 23 | 11.4 | 0.0023 |
Surgerya | 60 | 33.3 | 99 | 50.5 | 108 | 52.9 | 112 | 55.4 | <0.0001 |
Chemotherapy | 2 | 1.1 | 2 | 1.0 | 5 | 2.5 | 6 | 3.0 | 0.4290 |
Surgery+radiotherapy | 31 | 17.2 | 41 | 20.9 | 34 | 16.7 | 24 | 11.9 | 0.1149 |
Surgery+chemotherapy | 11 | 6.1 | 5 | 2.6 | 6 | 2.9 | 8 | 4.0 | 0.2777 |
Chemotherapy+radiotherapy | 13 | 7.2 | 1 | 0.5 | 2 | 1.0 | 8 | 4.0 | 0.0004 |
Surgery+radio+chemotherapy | 8 | 4.4 | 3 | 1.5 | 11 | 5.4 | 10 | 5.0 | 0.2043 |
Supportive care | 11 | 6.1 | 10 | 5.1 | 12 | 5.9 | 11 | 5.4 | 0.9745 |
Locally advanced disease | |||||||||
Radiotherapya | 28 | 53.8 | 49 | 70.0 | 39 | 40.6 | 12 | 12.9 | <0.0001 |
Chemotherapy | 7 | 13.5 | 3 | 4.3 | 12 | 12.5 | 11 | 11.8 | 0.2720 |
Chemotherapy+surgery | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 2.2 | 0.2419 |
Chemo+radiotherapya | 11 | 21.2 | 9 | 12.9 | 29 | 30.2 | 55 | 59.1 | <0.0001 |
Chemo+surgery+radiotherapy | 0 | 0.0 | 3 | 4.3 | 6 | 6.3 | 4 | 4.3 | 0.3247 |
Supportive care | 6 | 11.5 | 6 | 8.6 | 10 | 10.4 | 9 | 9.7 | 0.9552 |
Metastatic disease | |||||||||
Radiotherapya | 28 | 31.1 | 30 | 24.6 | 17 | 11.5 | 8 | 4.6 | <0.0001 |
Chemotherapya | 24 | 26.7 | 32 | 26.2 | 64 | 43.2 | 113 | 65.3 | <0.0001 |
Chemotherapy+surgery | 0 | 0.0 | 1 | 0.8 | 1 | 0.7 | 2 | 1.2 | 0.9155 |
Chemo+radiotherapya | 17 | 18.9 | 4 | 3.3 | 15 | 10.1 | 10 | 5.8 | 0.0003 |
Surgery | 0 | 0.0 | 0 | 0.0 | 1 | 0.7 | 0 | 0.0 | 0.6754 |
Chemo+radiotherapy+surgery | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.6 | 0.9999 |
Supportive care | 21 | 23.3 | 55 | 45.1 | 50 | 33.8 | 39 | 22.5 | 0.0002 |
Linear trend significant